As partners in the EU-funded WISDOM project, Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki and
Health data can be extremely useful for research, innovation, and development, but can only be freely utilized if identifying
AI-based next-generation anonymization technology developed in Finland enables versatile and high-quality research utilization of health data. Bayer, a pharmaceutical
